Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm


Oestrogen receptor (ER) is a good prognostic marker for the treatment of breast cancers. Upregulation of metastatic tumour antigen 1 (MTA1) is associated with the invasiveness and metastatic potential of several human cancers1,2 and acts as a co-repressor of nuclear ER-α3. Here we identify a naturally occurring short form of MTA1 (MTA1s) that contains a previously unknown sequence of 33 amino acids with an ER-binding motif, Leu-Arg-Ile-Leu-Leu (LRILL). MTA1s localizes in the cytoplasm, sequesters ER in the cytoplasm, and enhances non-genomic responses of ER. Deleting the LRILL motif in MTA1s abolishes its co-repressor function and its interaction with ER, and restores nuclear localization of ER. Dysregulation of human epidermal growth factor receptor-2 in breast cancer cells enhances the expression of MTA1s and the cytoplasmic sequestration of ER. Expression of MTA1s in breast cancer cells prevents ligand-induced nuclear translocation of ER and stimulates malignant phenotypes. MTA1s expression is increased in human breast tumours with no or low nuclear ER. The regulation of the cellular localization of ER by MTA1s represents a mechanism for redirecting nuclear receptor signalling by nuclear exclusion.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: MTA1s is a variant of MTA1.
Figure 2: MTA1s is cytoplasmic and interacts with ER.
Figure 3: MTA1s LXXLL motif required for interaction and sequestration of ER.
Figure 4: Expression of MTA1s in human breast tumours.


  1. Toh, Y., Pencil, S. D. & Nicolson, G. L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269, 229–263 (1994)

    Google Scholar 

  2. Nawa, A. et al. Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J. Cell. Biochem. 79, 202–212 (2000)

    Article  CAS  Google Scholar 

  3. Mazumdar, A. et al. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biol. 3, 30–37 (2001)

    Article  CAS  Google Scholar 

  4. Shapiro, M. B. & Senapathy, P. RNA splices junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acid Res. 15, 7155–7174 (1987)

    Article  CAS  Google Scholar 

  5. Crawford, J., Ianzano, L. & Savino, M. The PISSLRE gene: structure, exon skipping and exclusion as tumour suppressor in breast cancer. Genomics 56, 90–97 (1999)

    Article  CAS  Google Scholar 

  6. Benz, C. C. et al. Estrogen-dependent, taxoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu. Breast Cancer Res. Treat. 24, 85–95 (1992)

    Article  CAS  Google Scholar 

  7. Kumar, R. et al. Overexpression of HER2 modulates Bcl-2, Bcl-XL and Tamoxifen-induced apoptosis in human MCF-7 breast cancer cells. Clin. Cancer Res. 2, 1215–1219 (1996)

    CAS  PubMed  Google Scholar 

  8. Vadlamudi, R. et al. PELP1, a novel human protein that acts as a bifunctional regulator of steroid receptors. J. Biol. Chem. 276, 38272–38279 (2001)

    CAS  PubMed  Google Scholar 

  9. Henttu, P. M., Kalkhoven, E. & Parker, M. G. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17, 1832–1839 (1997)

    Article  CAS  Google Scholar 

  10. Kumar, V. et al. Functional domains of the human estrogen receptor. Cell 51, 941–951 (1987)

    Article  CAS  Google Scholar 

  11. Berry, B. et al. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl Acad. Sci USA 86, 1218–1222 (1989)

    Article  ADS  CAS  Google Scholar 

  12. Migliaccio, A. et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15, 1292–1300 (1996)

    Article  CAS  Google Scholar 

  13. Catoria, G. et al. Non-transcriptional action of oestradiol and orogestrin triggers DNA synthesis. EMBO J. 18, 2500–2510 (1999)

    Article  Google Scholar 

  14. Song, R.-X. et al. Linkage of estrogen action to MAP kinase activation through ERα association with Shc signalling pathway. Mol. Endocrinol. 16, 116–127 (2002)

    CAS  PubMed  Google Scholar 

  15. Mandal, M. et al. Growth factors regulation of heterogeneous nuclear ribonucleoprotein expression and functions. J. Biol. Chem. 276, 9699–9704 (2001)

    Article  CAS  Google Scholar 

Download references


We thank B. S. Katzenellenbogen and M. R. Parker for AF2 fusion protein; D. McDonnell for 3X-ERE TATA; D. Shapiro for ERE-reporter systems; D. Nguyen for cloning; and W. Schmid for the GRE-CAT promoter constructs. Susan G. Komen Breast Cancer Foundation and National Institutes of Health grants (to R.K.) supported this study.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Rakesh Kumar.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kumar, R., Wang, RA., Mazumdar, A. et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm. Nature 418, 654–657 (2002).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing